Crucially, it has been shown that increased expression Bcl-xL is associated with high risk of metastasis, reduced sensitivity to chemotherapeutic treatments and poor prognosis,34, 35 implying possible involvement of BC200 as an oncogenic lncRNA during breast cancer progression. Here, BCL2L1 is linked to breast carcinoma.